Central Hospital, Nancy, France: Shock trials

The registry lists 11 Shock studies with Central Hospital, Nancy, France as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 2 1Phase 3 1Phase 4 2No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Left Ventricular Outflow Tract Mean Velocity in Children: a Strong Alternative to Cardiac Index in Pediatric Intensive Care UnitCompletedNCT06837727
• Use of Ultrasound in the Initial Management of Patients in Shock in the Nancy Emergency DepartmentActive, not recruitingNCT06573541
• Safety Profile of the Combination of Levosimendan and IV Beta Blocker in Cardiogenic Shock: a Retrospective StudyStatus unknownNCT04938375
• Fluid REsponsiveness and Arterial ELASTANCE in Patients With Septic Shock or After Aortic SurgeryStatus unknownNCT04388267
• Norepinephrine vs Norepinephrine and Dobutamine in Cardiogenic ShockStatus unknownNCT03340779Phase 3
• Impact of Adrenoreceptor Expressions on Inflammatory Pattern in Refractory Cardiogenic Shock Under VA ECMOCompletedNCT03327493Not applicable
• Modulation of Vasoreactivity in Septic Shock: Impact of Recombinant Protein CCompletedNCT02885168Phase 4
• Effects of Induced Moderate HYPOthermia on Mortality in Cardiogenic Shock Patients Rescued by Veno-arterial ExtraCorporeal Membrane Oxygenation (ECMO)CompletedNCT02754193Not applicable
• Characterization of Hemostatic Disordres in Septic Shock: Searching for Biological MarkersStatus unknownNCT02692053Not applicable
• Esmolol Effects on Heart and Inflammation in Septic ShockStatus unknownNCT02068287Phase 2
• Study Comparing the Efficacy and Tolerability of Epinephrine and Norepinephrine in Cardiogenic ShockCompletedNCT01367743Phase 4